Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert – Yahoo Finance

Mang. Const.

Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert  Yahoo Finance

NDA Partners Chairman Carl Peck, MD, announced today that Klaus Peter Hoffmann, MD, PhD, a well-respected preclinical drug development expert with a …

Source: Mang. Const.